N G Industries Ltd
₹ 163
-2.86%
22 Nov
- close price
About
Incorporated in 1994, N G Industries Ltd is in the business of Healthcare services[1]
Key Points
- Market Cap ₹ 54.7 Cr.
- Current Price ₹ 163
- High / Low ₹ 230 / 136
- Stock P/E 9.36
- Book Value ₹ 124
- Dividend Yield 2.14 %
- ROCE 6.50 %
- ROE 5.63 %
- Face Value ₹ 10.0
Pros
- Company is almost debt free.
- Company has been maintaining a healthy dividend payout of 27.4%
Cons
- The company has delivered a poor sales growth of -0.91% over past five years.
- Tax rate seems low
- Company has a low return on equity of 6.20% over last 3 years.
- Earnings include an other income of Rs.5.65 Cr.
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Sector: Healthcare Industry: Healthcare
Loading peers table ...
Quarterly Results
Figures in Rs. Crores
Profit & Loss
Figures in Rs. Crores
Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | TTM | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
14.13 | 13.80 | 14.86 | 16.93 | 17.28 | 17.36 | 17.67 | 18.50 | 11.88 | 18.42 | 18.70 | 16.88 | 16.10 | |
11.18 | 11.06 | 12.20 | 13.80 | 14.40 | 14.30 | 14.85 | 15.71 | 10.62 | 16.06 | 16.81 | 14.87 | 14.35 | |
Operating Profit | 2.95 | 2.74 | 2.66 | 3.13 | 2.88 | 3.06 | 2.82 | 2.79 | 1.26 | 2.36 | 1.89 | 2.01 | 1.75 |
OPM % | 20.88% | 19.86% | 17.90% | 18.49% | 16.67% | 17.63% | 15.96% | 15.08% | 10.61% | 12.81% | 10.11% | 11.91% | 10.87% |
0.77 | 0.57 | 0.53 | -0.07 | -0.02 | -0.24 | -0.34 | -0.05 | 0.14 | 1.63 | 8.37 | 4.51 | 5.65 | |
Interest | 0.14 | 0.29 | 0.04 | 0.06 | 0.07 | 0.08 | 0.18 | 0.16 | 0.08 | 0.09 | 0.09 | 0.07 | 0.01 |
Depreciation | 0.73 | 0.93 | 1.19 | 0.58 | 0.57 | 0.60 | 0.57 | 0.56 | 0.49 | 0.58 | 0.52 | 0.60 | 0.60 |
Profit before tax | 2.85 | 2.09 | 1.96 | 2.42 | 2.22 | 2.14 | 1.73 | 2.02 | 0.83 | 3.32 | 9.65 | 5.85 | 6.79 |
Tax % | 27.02% | 27.75% | 27.04% | 36.78% | 36.04% | 34.11% | 34.68% | 27.72% | 25.30% | 21.39% | 13.78% | 14.02% | |
2.08 | 1.52 | 1.43 | 1.53 | 1.42 | 1.41 | 1.12 | 1.47 | 0.61 | 2.61 | 8.32 | 5.03 | 5.84 | |
EPS in Rs | 6.21 | 4.54 | 4.27 | 4.57 | 4.24 | 4.21 | 3.34 | 4.39 | 1.82 | 7.79 | 24.83 | 15.01 | 17.42 |
Dividend Payout % | 56.37% | 77.14% | 81.99% | 76.63% | 82.57% | 83.16% | 104.69% | 0.00% | 0.00% | 44.92% | 14.09% | 23.31% |
Compounded Sales Growth | |
---|---|
10 Years: | 2% |
5 Years: | -1% |
3 Years: | 12% |
TTM: | -6% |
Compounded Profit Growth | |
---|---|
10 Years: | 2% |
5 Years: | 5% |
3 Years: | 41% |
TTM: | 17% |
Stock Price CAGR | |
---|---|
10 Years: | 9% |
5 Years: | 23% |
3 Years: | 49% |
1 Year: | 0% |
Return on Equity | |
---|---|
10 Years: | 9% |
5 Years: | 7% |
3 Years: | 6% |
Last Year: | 6% |
Balance Sheet
Figures in Rs. Crores
Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Sep 2024 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Equity Capital | 3.35 | 3.35 | 3.35 | 3.35 | 3.35 | 3.35 | 3.35 | 3.35 | 3.35 | 3.35 | 3.35 | 3.35 | 3.35 |
Reserves | 10.82 | 10.97 | 10.99 | 11.11 | 8.97 | 8.50 | 7.62 | 5.99 | 11.66 | 20.56 | 24.85 | 32.79 | 38.36 |
4.59 | 1.85 | 1.07 | 1.17 | 1.91 | 1.48 | 1.25 | 3.02 | 0.27 | 0.51 | 0.59 | 1.18 | 1.25 | |
1.55 | 1.63 | 1.56 | 1.58 | 0.15 | 0.26 | 1.10 | 1.55 | 1.78 | 2.74 | 1.93 | 2.60 | 5.48 | |
Total Liabilities | 20.31 | 17.80 | 16.97 | 17.21 | 14.38 | 13.59 | 13.32 | 13.91 | 17.06 | 27.16 | 30.72 | 39.92 | 48.44 |
6.45 | 6.00 | 5.09 | 4.87 | 4.90 | 4.96 | 5.16 | 5.26 | 5.35 | 5.56 | 5.19 | 5.62 | 5.54 | |
CWIP | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Investments | 9.67 | 7.53 | 8.40 | 8.89 | 4.30 | 4.24 | 3.37 | 3.84 | 8.16 | 16.15 | 22.27 | 28.95 | 38.98 |
4.19 | 4.27 | 3.48 | 3.45 | 5.18 | 4.39 | 4.79 | 4.81 | 3.55 | 5.45 | 3.26 | 5.35 | 3.92 | |
Total Assets | 20.31 | 17.80 | 16.97 | 17.21 | 14.38 | 13.59 | 13.32 | 13.91 | 17.06 | 27.16 | 30.72 | 39.92 | 48.44 |
Cash Flows
Figures in Rs. Crores
Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
2.02 | 2.01 | 1.77 | 2.01 | 1.85 | 2.43 | 3.82 | 2.85 | 1.35 | -1.73 | 3.16 | -1.02 | |
-3.73 | 2.23 | -0.62 | -0.92 | -0.89 | -1.50 | -1.09 | -3.41 | 2.00 | 1.26 | -1.72 | 2.25 | |
1.75 | -4.12 | -2.16 | -1.30 | -0.68 | -1.84 | -1.75 | 0.27 | -2.78 | 0.22 | -1.11 | -0.60 | |
Net Cash Flow | 0.04 | 0.12 | -1.01 | -0.21 | 0.28 | -0.91 | 0.99 | -0.29 | 0.57 | -0.25 | 0.33 | 0.63 |
Ratios
Figures in Rs. Crores
Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Debtor Days | 2.07 | 1.59 | 4.67 | 6.47 | 8.87 | 9.67 | 10.74 | 9.27 | 10.14 | 15.46 | 1.37 | 3.24 |
Inventory Days | 60.53 | 64.93 | 54.21 | 55.81 | 61.32 | 58.24 | 53.13 | 41.48 | 64.81 | 155.87 | 34.69 | 52.74 |
Days Payable | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Cash Conversion Cycle | 62.60 | 66.52 | 58.87 | 62.28 | 70.19 | 67.92 | 63.87 | 50.75 | 74.95 | 171.33 | 36.05 | 55.98 |
Working Capital Days | -18.34 | -23.01 | -17.44 | -9.70 | 25.77 | 22.71 | 6.82 | -7.50 | -24.58 | 20.61 | -13.27 | 0.43 |
ROCE % | 15.67% | 13.86% | 11.08% | 17.98% | 16.68% | 18.80% | 18.71% | 19.77% | 6.87% | 10.68% | 6.58% | 6.50% |
Documents
Announcements
- Announcement under Regulation 30 (LODR)-Newspaper Publication 15 Nov
-
Board Meeting Outcome for Approval Of Unaudited Financial Results For Quarter And Six Months Ended 30Th September, 2024
13 Nov - Outcome of Board Meeting and financial results for Q2 2024.
-
Financial Results For Quarter And Half Year Ended 30Th September, 2024
13 Nov - Outcome of Board Meeting and financial results for Q2 2024.
-
Board Meeting Intimation for Consideration And Approval Of Unaudited Financial Results For Quarter And Half Year Ended 30Th September, 2024
5 Nov - Board meeting on November 13 to approve Q2 results.
- Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 13 Oct
Annual reports
-
Financial Year 2024
from bse
-
Financial Year 2023
from bse
-
Financial Year 2022
from bse
-
Financial Year 2021
from bse
-
Financial Year 2020
from bse
-
Financial Year 2019
from bse
-
Financial Year 2018
from bse
-
Financial Year 2017
from bse
-
Financial Year 2016
from bse
-
Financial Year 2015
from bse
-
Financial Year 2014
from bse
-
Financial Year 2013
from bse
-
Financial Year 2012
from bse
-
Financial Year 2011
from bse
-
Financial Year 2010
from bse
Business Overview:[1]
Company provides comprehensive healthcare services ranging from Clinics, Diagnostics, Inpatient & Outpatient Services, Pharmacy dispensing, etc.